Merkel Cell Carcinoma: A Complete Response to Avelumab Immunotherapy
Merkel cell carcinoma is an aggressive form of cancer with poor prognosis, particularly for individuals deemed unsuitable for surgical resection. With new immunotherapy agents being used alone or as an adjuvant treatment, improving long term outcomes are being seen, even for those deemed to be treated with palliative intent.
Authors
- Eamonn Byrne (ORCID: https://orcid.org/0000-0002-3056-8081)
- Eoin Conlon
- Mel Corbett (ORCID: https://orcid.org/0000-0001-5320-1015)
- Fergal O'Duffy
Institutions
- University College Dublin (IE)
- Mater Misericordiae University Hospital (IE)
- St. Vincent's University Hospital (IE)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/ccr3.71768
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00